Latest Research
Selectivity, efficacy and safety of JAKinibs: new evidence for a still evolving story. Ann Rheum Dis. November 2023
Definition of rheumatoid arthritis flare based on SDAI and CDAI. Ann Rheum Dis. October 2023
![](/fileadmin/_processed_/4/1/csm_FEE_2852_S2_263fd0a7e7.jpg)
Research Group of Helga Lechner-Radner
![](/fileadmin/_processed_/d/3/csm_FEE_2716_S_ac4da347fa.jpg)
Research Group of Peter Mandl
We perform and interpret imaging studies encompassing all manifestations of rheumatic and musculoskeletal diseases and develop new diagnostic and therapeutic methods targeting fibroblasts.
![](/fileadmin/_processed_/e/d/csm_FEE_2245_a80bdc1d40.jpg)
Research Group of Clemens Scheineker
Autoimmunity and ImmunodeficiencyWe study, treat and manage patients with immune mediated inflammatory diseases as well as patients with primary or secondary immunodeficiencies.
![](/fileadmin/_processed_/9/0/csm_FEE_2972_15795ad52f.jpg)
Research Group of Daniela Sieghart - Biomarkers in rheumatic disorders
Biomarkers in rheumatic disordersWe study autoantibodies as potential biomarkers for diagnosis, management and prognosis of rheumatic conditions.
![](/fileadmin/_processed_/6/2/csm_Paul_Website_9e0e9724c2.jpg)
Research Group of Paul Studenic
We try to understand the validity of outcomes used in measuring disease activity, progression, quality of life and the interaction of patients with the health care system.